At the 5 mg dose of tirzepatide, 5.1% of participants (32 cases) experienced hair loss
External resources New England Journal of Medicine - Phase 2 Retatrutide Trial Results ClinicalTrials.gov - TRIUMPH Phase 3 Study Information In case I do not see you, good afternoon, good evening, and good night
In the meantime, restricted access creates disparities in treatment availability, limits geographic expansion, and introduces frustration for healthcare providers and patients alike
For a 2mg dose: 2mg = 2,000 mcg 2,000 mcg / 10,000 mcg/mL = 0.2mL 0.2mL x 100 = 20 units For a 6mg dose: 6mg = 6,000 mcg 6,000 mcg / 10,000 mcg/mL = 0.6mL 0.6mL x 100 = 60 units For a 12mg dose: 12mg = 12,000 mcg 12,000 mcg / 10,000 mcg/mL = 1.2mL 1.2mL x 100 = 120 units The same formula works at any concentration
For in vitro research use only
Ethics declarations Competing interests I.S